JPS63222113A - Plaster composition - Google Patents

Plaster composition

Info

Publication number
JPS63222113A
JPS63222113A JP5604787A JP5604787A JPS63222113A JP S63222113 A JPS63222113 A JP S63222113A JP 5604787 A JP5604787 A JP 5604787A JP 5604787 A JP5604787 A JP 5604787A JP S63222113 A JPS63222113 A JP S63222113A
Authority
JP
Japan
Prior art keywords
water
active ingredient
composition
oil
oily
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5604787A
Other languages
Japanese (ja)
Other versions
JPH0567127B2 (en
Inventor
Shigeru Moriwaki
繁 森脇
Mikio Furukawa
幹夫 古川
Tomonori Morioka
智紀 森岡
Kenji Hara
健次 原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP5604787A priority Critical patent/JPS63222113A/en
Publication of JPS63222113A publication Critical patent/JPS63222113A/en
Publication of JPH0567127B2 publication Critical patent/JPH0567127B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a plaster composition having high cooling effects and raised releasability and percutaneous absorption of active ingredient, containing a water-soluble high polymer substance, an oil component, water, an oily gelatinizing agent and an active ingredient. CONSTITUTION:(A) 1-30wt.% preferably 2-15wt.% water-soluble high polymer substance (e.g. gelatin, PVA or xanthan gum) is blended with (B) 2-20wt.%, preferably 2.5-10wt.% oil component (preferably primary alcohol fatty acid) except an active ingredient, (C) >=30wt.%, preferably 40-75wt.% water content, (D) 1-15wt.%, preferably 2-10wt.% oily gelatinizing agent, preferably anhydrous light silica having 5-100mum average particle diameter of primary particles and (E) 0.01-20wt.% active ingredient such as methyl salicylate, indomethacin or peppermint oil). Although the composition contains the oil composition, the composition has no oozing of the oil component, no sag and no reduction in adhesivity by the action of the oily gelatinizing agent and shown excellent effects by application to the affected part.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は貼付剤組成物、更に詳細には、有効成分の膏体
からの放出性及び経皮吸収性を高めた貼付剤組成物に関
する。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a patch composition, and more particularly to a patch composition in which the release of active ingredients from a plaster and the percutaneous absorption thereof are improved.

〔従来の技術〕[Conventional technology]

貼付剤、就中湿布剤、79ツデ剤等の親水性貼付剤は、
肩こり、腰痛、打ち身、捻挫、筋肉痛等の疾患部位に貼
付して用いる外用剤でろる。そして、その効果は、有効
成分による効果のほかに、と九に含まれる水や油による
有効成分の経皮吸収促進効果、水による冷却効果、膏体
等による保護効果によるものと考えられている。
Hydrophilic patches such as patches, poultices, and 79 Tsude preparations are:
It is an external preparation that is applied to areas affected by stiff shoulders, lower back pain, bruises, sprains, muscle pain, etc. In addition to the effect of the active ingredients, this effect is thought to be due to the water and oil contained in Toku, which promotes transdermal absorption of the active ingredients, the cooling effect of water, and the protective effect of plasters, etc. .

従来、貼付剤は、一般に、カオリン、メルク、ベントナ
イト、二酸化チタン、酸化亜鉛等の無機粉体を賦形剤と
し、これに水溶性高分子物質:グリセリン、ソルビトー
ル、?リエチレングリコール等の保湿剤;水及び有効成
分を加え練合して得られるペースト状の膏体を紙、織布
、不織布、プラスチックフィルム等の支持体(バッキン
グ)に塗布して調製されている。
Conventionally, patches have generally used inorganic powders such as kaolin, Merck, bentonite, titanium dioxide, and zinc oxide as excipients, and water-soluble polymeric substances such as glycerin, sorbitol, etc. Humectants such as lyethylene glycol; prepared by adding and kneading water and active ingredients and applying a paste-like paste to a support (backing) such as paper, woven fabric, non-woven fabric, or plastic film.

〔発明が解決しようとする問題点〕[Problem that the invention seeks to solve]

ところで、膏体中の水分及び油分は、上述した如く冷却
効果を奏すると共に、有効成分の経皮吸収を高める作用
を有する。
By the way, the water and oil content in the paste has a cooling effect as described above, and also has the effect of increasing transdermal absorption of the active ingredient.

しかしながら、従来、貼付剤の膏体中に水分を多く含ん
だ系において安定に含有させることの出来る油分の量に
は制限かぁって、(にしみ出し、ダレの原因となるため
有効成分以外の油分は出来るだけ排除されていた。その
ため、有効成分の膏体からの放出性及び経皮吸収性が充
分でなく、自ずから従来の貼付剤は速効性、持続性に欠
けるという欠点がめった。
However, in the past, there was a limit to the amount of oil that could be stably contained in a patch with a high water content (because it could cause oozing and sagging), it was difficult to use oil other than the active ingredient. Oil content was excluded as much as possible.As a result, the release of the active ingredient from the plaster and its transdermal absorption were insufficient, and conventional patches often lacked quick-acting and long-lasting effects.

〔問題点を解決するための手段〕[Means for solving problems]

斯かる実状において、本発明者は鋭意研究を行った結果
、水溶性高分子物質、有効成分以外の油成分(以下、「
油成分」と称することもある)、油性グル化剤及び全組
成の30%以上の水分を配合して調製した貼付側組成物
がしみ出しやブレがなく有効成分の膏体からの放出性及
び経皮吸収性において極めて優れていることを見出し、
本発明を完成した。
Under such circumstances, the present inventor conducted intensive research and found that water-soluble polymer substances and oil components other than active ingredients (hereinafter referred to as "
The patch-side composition prepared by blending an oil-based gluing agent (sometimes referred to as "oil component"), and 30% or more water of the total composition has the ability to release the active ingredient from the paste without oozing or blurring. We discovered that it has excellent transdermal absorption.
The invention has been completed.

すなわち、本発明は、水溶性高分子物質1〜30重量%
、有効成分以外の油成分2〜20重量%、水分307E
[t%以上、油性ゲル化剤1〜15重量%及び有効成分
を含有することを特徴とする貼付側組成物を提供するも
のである。
That is, in the present invention, 1 to 30% by weight of a water-soluble polymer substance
, oil components other than active ingredients 2 to 20% by weight, moisture 307E
[This invention provides a patch-side composition characterized by containing 1 to 15% by weight of an oil-based gelling agent and an active ingredient.

本発明において、水溶性高分子物質としては、例えばゼ
ラチン、ベクチ/、?リアクリル酸、?リアクリル酸ソ
ーダ、アルギン酸ソーダ、?リピニルアルコール、ポリ
ビニルピロリド/、?リピニルカル4?キシ共重合体、
?リピニルビロリドンΦビニルアセテート共重合体、?
リエチレンオキサイド、カルボキンメチルセルロース、
ヒドロキンメチルセルロース、ヒドロキシエチルセルロ
ース、メチルセルロース、エチルセルロース、キサンタ
ンガム、アラビアガム、トラガントガム、カラヤガム、
メトキシエチレン及び無水マレイン酸共重金物等が挙げ
られ、これらは1種又は2種以上を用いることができる
。これらの水溶性高分子物質は、組成物全体の1〜30
%、好ましくは2〜15%配合される。
In the present invention, water-soluble polymeric substances include, for example, gelatin, vector, etc. Lyacrylic acid? Sodium acrylate, sodium alginate? Lipinyl alcohol, polyvinylpyrrolid/? Lipinircal 4? xy copolymer,
? Lipinyl pyrrolidone Φ vinyl acetate copolymer,?
Liethylene oxide, carboxin methylcellulose,
Hydroquine methylcellulose, hydroxyethylcellulose, methylcellulose, ethylcellulose, xanthan gum, gum arabic, gum tragacanth, gum karaya,
Examples include methoxyethylene and maleic anhydride co-heavy metals, and these may be used alone or in combination of two or more. These water-soluble polymer substances account for 1 to 30% of the total composition.
%, preferably 2 to 15%.

油成分としては、例えば−級アルコール脂肪酸エステル
;スクアレン、スクワラン、deす;Ifン、流動、Q
ラフイン等の高級炭化水素;シリコーン油等の含ケイ素
化合物;モノグリセリド、ジグリセリド、トリグリセリ
ド等の脂肪酸グリセリンエステル類等が挙げられる。そ
の中でも、次の一般式%式% (式中、R1は炭素数2〜18の、島は炭素数1〜18
の直鎖もしくは分岐アルキル基を示す)で表わされる一
級アルコール脂肪酸エステルが好ましく、就中ミリスチ
ン酸イソプロピル、ミリスチン酸オクチルドデシルは当
該放出性、経皮吸収性の向上効果が高く、しかも皮膚刺
激が少ないため特に好ましい。これらの配合量は全組成
の2〜20%、好ましくは2.5〜10%である。
Examples of oil components include -grade alcohol fatty acid ester; squalene, squalane, desu;
Examples include higher hydrocarbons such as rough-in; silicon-containing compounds such as silicone oil; and fatty acid glycerin esters such as monoglyceride, diglyceride, and triglyceride. Among them, the following general formula % formula % (in the formula, R1 has 2 to 18 carbon atoms, and the island has 1 to 18 carbon atoms)
Primary alcohol fatty acid esters represented by (representing a straight chain or branched alkyl group) are preferred, and among these, isopropyl myristate and octyldodecyl myristate have a high effect of improving release properties and percutaneous absorption, and are less irritating to the skin. Therefore, it is particularly preferable. The blending amount of these is 2 to 20%, preferably 2.5 to 10% of the total composition.

油性ゲル化剤としては、例えばゾペンゾリデンソルピト
ール、12−ヒドロキシステアリン酸、ステアリン酸金
属塩、アシル化アミノ酸、シリカ剤、エチレンビニルア
セテート共重合体、スチレン−エチレン−フチレンース
チレンフクック共重合体、スチレン−イソプレン−スチ
レンブロック共重合体、スチレンープタゾエンースチレ
ンブロック共重合体等が挙げられる。これらの中でも、
貼付側組成物中の含水量が多いことを考慮すると7リカ
剤が好ましく、そのシリカ剤の中でも無水軽質シリカ、
特に−次粒子の平均径が1〜500mμ、更に好ましく
は5〜100mμのものが好ましい0 この油性グル化剤は、貼付側組成物中の油成分の分散、
均一性を安定化し、油成分のしみ出しを抑える作用を奏
するので、皮膚へのべたつきがない良好な貼付側組成物
が得られる。この油性ゲル化剤の配合量は、全組成の1
〜15%、特に2〜10%が好ましい。
Examples of oil-based gelling agents include zopenzolidenesorpitol, 12-hydroxystearic acid, stearic acid metal salts, acylated amino acids, silica agents, ethylene vinyl acetate copolymers, and styrene-ethylene-phthylene-styrene hooks. Examples include copolymers, styrene-isoprene-styrene block copolymers, styrene-ptazoene-styrene block copolymers, and the like. Among these,
Considering the high water content in the patch composition, 7 silica agents are preferred, and among these silica agents, anhydrous light silica,
In particular, it is preferable that the average diameter of the secondary particles is 1 to 500 mμ, more preferably 5 to 100 mμ. This oil-based gluing agent is used to disperse the oil component in the patch-side composition,
Since it has the effect of stabilizing the uniformity and suppressing the seepage of oil components, a good patch-side composition that is not sticky to the skin can be obtained. The amount of this oil-based gelling agent is 1% of the total composition.
~15%, especially 2-10% is preferred.

更に、本発明貼付剤組成物には水分を30%以上配合す
ることが必須でるり、これ未満では本発明の効果は奏さ
れない。特に水分を全組成の40〜75%配合するのが
好ましい。
Furthermore, it is essential that the patch composition of the present invention contains 30% or more of water; if it is less than this, the effects of the present invention will not be achieved. In particular, it is preferable to mix water in an amount of 40 to 75% of the total composition.

また、有効成分としては、斯かる場合に一般に使用され
ている、例えばサリチル酸メチル、サリチル酸グリコー
ル、インドメタシン、!−メントール、ハツカ油、ユー
カリ油、dl−カンフルトウガラシエキス、ノニル酸ワ
ニリルアミド、酢酸トコフェロール、ソフエンヒトラミ
ン、マレイン酸りaルフエニラミン、チモール等の1種
又は2種以上が配合される。この配合量は、一般に0.
01〜20%が好ましい。
In addition, as active ingredients, commonly used in such cases, for example, methyl salicylate, glycol salicylate, indomethacin, etc. - One or more of menthol, pepper oil, eucalyptus oil, dl-camphor capsicum extract, vanillylamide nonylate, tocopherol acetate, sophenhydramine, alpha maleic acid, thymol, etc. are blended. This amount is generally 0.
01-20% is preferred.

本発明の貼付側組成物には、上記必須成分のほかに、必
要に応じて、貼付剤に一般に使用嘔れている、例えば、
プロピレングリコール、グリセリン、ンルピトール、−
リエテレ/グリコール、乳酸す) +3ウム等の保湿剤
の1種又は2種以上(配合量は通常、組成物全体の5〜
30%);カオリン、メルク、ベントナイト、二酸化チ
タン、酸化亜鉛等の無機粉体の1種又は2種以上(配合
量は通常O〜30%);更に膏体物性(柔軟性、粘着性
、保型性等)の調整を目的とする昶リプテン、アクリル
樹脂エマルション、酢酸ビニルエマルショア等の高分子
物質等を配合することができる。
In addition to the above-mentioned essential ingredients, the patch composition of the present invention may optionally contain ingredients commonly used in patches, such as:
Propylene glycol, glycerin, lupitor, -
One or more types of humectants such as Lietere/glycol, lactic acid) +3um (the amount added is usually 5 to 50% of the total composition)
30%); one or more inorganic powders such as kaolin, Merck, bentonite, titanium dioxide, and zinc oxide (the blending amount is usually 0 to 30%); Polymeric substances such as lipten, acrylic resin emulsion, vinyl acetate emulsion, etc. can be blended for the purpose of adjusting moldability, etc.).

本発明の貼付剤組成物は、上記成分を常法によって混合
することKより調製される。この貼付剤組成物は紙、織
布、不織布、プラスチックフィルム等の支持体に塗布し
、更に必要にょシ?リエチレンフィルム等の7エイシン
グを施して貼付剤とする。
The patch composition of the present invention is prepared by mixing the above components in a conventional manner. This patch composition is applied to a support such as paper, woven fabric, non-woven fabric, plastic film, etc., and then applied as needed. Apply 7A coating such as polyethylene film to make a patch.

〔発明の効果〕〔Effect of the invention〕

本発明貼付剤組成物は、多量の水分及び油成分を含有し
ているので、従来の膏体に比較して冷却効果が高いと共
に、有効成分の膏体からの放出性及び経皮吸収性に優れ
ている。また本発明貼付剤組成物は油成分を含有するが
、油性ゲル化剤の作用にエフ油成分のしみ出し、ダレ粘
着性の低下もなく疾患部位に貼付されて優れた効果を奏
する。
Since the patch composition of the present invention contains a large amount of water and oil components, it has a higher cooling effect than conventional plasters, and also has improved release of active ingredients from the plaster and transdermal absorption. Are better. Furthermore, although the adhesive patch composition of the present invention contains an oil component, it can be applied to diseased areas and exhibits excellent effects without any oozing of the F oil component or decrease in sagging tackiness due to the action of the oil-based gelling agent.

〔実施例〕〔Example〕

次に実施例を挙げて本発明を更に詳しく説明する0 実施例1 下記の処方で、常法にエフ貼付剤組成物を調製し、これ
を湿布側膏体として不織布又はリント布の上に塗布し、
更に一すエチレンフイルムを施して湿布剤とした。
Next, the present invention will be described in more detail with reference to Examples.0 Example 1 An F patch composition was prepared in a conventional manner according to the following formulation, and this was applied as a poultice on a nonwoven fabric or lint cloth. death,
A poultice was further coated with an ethylene film.

実施例1 ■?リアクリル酸ソーダ       4.0(70ン
ピスSS9日本純薬工業■) ■?リアクリル酸           1.5(ゾユ
リマーAC−10H,日本綿薬工業■)■グリセリン 
          10.0■薬効成分 サリチル酸
グリコール      1.Oj−メントール    
      1.0■ミリスチン酸オクチルドデクル 
        3.0■?リソルベート80    
     2.0■硫酸アルミニウム        
 0・5■無水軽質シリカ          4・0
■水                残金   計 
            100.0%得られた湿布剤
は、有効成分の放出性、経皮吸収性及び粘着性に優れて
いた。
Example 1 ■? Sodium lyacrylate 4.0 (70 mp SS9 Nippon Pure Chemical Industries ■) ■? Lyacrylic acid 1.5 (Zoyurimer AC-10H, Nippon Cotton Pharmaceutical Co., Ltd.) ■Glycerin
10.0■Medicinal ingredients Glycol salicylate 1. Oj-menthol
1.0■ Octyldodecyl myristate
3.0■? resolvate 80
2.0 ■ Aluminum sulfate
0.5■ Anhydrous light silica 4.0
■Water balance total
The poultice obtained at 100.0% had excellent release properties of the active ingredient, transdermal absorbability, and adhesiveness.

実施列2及び3 下記第1表に示す処方で常法にJ:り貼付剤組成物を調
製し、これを湿布側膏体として不織布又はリント布の上
に塗布し、更に?リエチレンフイルムを施して湿布剤と
した。
Examples 2 and 3 A patch composition was prepared in a conventional manner according to the formulation shown in Table 1 below, and this was applied as a poultice on a nonwoven fabric or lint cloth, and then... A poultice was prepared by applying a polyethylene film.

以下余白 上で得た湿布剤について有効成分の放出性、経皮吸収性
及び粘着性を調べた。比較例として、実施例2.3から
ミリスチン酸オクチルドデシルを除い九もの(比較P1
1)及び実施例2.3からそれぞれ無水軽質シリカを除
いたもの(比較例2゜3)を用いた。
The release properties of the active ingredient, transdermal absorption, and adhesiveness of the poultice obtained above were examined below. As a comparative example, nine samples were prepared from Example 2.3 except for octyldodecyl myristate (comparative P1).
1) and Example 2.3 from which anhydrous light silica was removed (Comparative Example 2.3).

伺放出性、経皮吸収性及び粘着性は次の如くして測定し
念〇 放 出 性:薬物保持槽、スクワラン処理ニトロセルa
−ス膜及び試料採取管付受器 からなる拡散セル装置を用いた。
Release properties, transdermal absorption properties, and adhesion were measured as follows: Drug holding tank, squalane-treated Nitrocell a
- A diffusion cell device consisting of a gas membrane and a receptacle with a sample collection tube was used.

受器内をυノ酸生塩緩衝液で充念し た後、薬物保持槽中に各膏体を充填 し、受器内を攪拌しながら膜を介し て受器中に放出される薬物濃度を経 時的に測定した。Fill the container with υnoic acid raw salt buffer. After that, fill each paste into the drug holding tank. and pass through the membrane while stirring the inside of the receiver. The concentration of drug released into the receiver Measured over time.

経皮吸収性:白色家兎(15羽、各群5羽)の腹部を別
宅し、各ノ9ツゾ剤を貼付後、 経時的に採血して薬物の血中濃度を 測定した。
Transdermal absorption: The abdomens of white rabbits (15 rabbits, 5 in each group) were placed in a separate house, each No9tsuzo drug was applied, and blood was collected over time to measure the drug concentration in the blood.

粘 着 性: JISタック試験法(球転法)により測
定した。
Adhesion: Measured by JIS tack test method (ball rolling method).

結果を第1図、第2図及び第2表に示す。The results are shown in FIG. 1, FIG. 2, and Table 2.

第  2  表Table 2

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明貼付側組成物の有効成分(サリチル酸グ
リコール)の放出性を示す図で7bJ)、第2図は同有
効成分の経皮吸収性を示す図でろる0以上 日 一   もコも東騒Q−1′l!5÷範回手続補正書(
自発) 昭和62年4 月138 1、 事件の表示 昭和62年 特 許  願第56047号2、発明の名
称 貼付剤組成物 3、 補正をする者 事件との関係   出願人 住所 名称 (091)花王株式会社 4、代理人 氏 名 (6870)弁理士 有 賀 三 娘 、−1
1住 所 同    上          皇二了。 氏 名 (7756)弁理士 高 野 登志雄 ’::
l’i・     1 住 所 同    上         1−−二J6
、補正の対象 明細書の「発明の詳細な説明」の欄 7、補正の内容 (1)明細書中、第6頁第12行 「dj−カンフルト」とらるを 「dl−カンフル、ト」と訂正する。 (2)同、第7頁第3行 「5〜30%」とあるを 「5〜50%」と訂正する。
Figure 1 shows the release properties of the active ingredient (glycol salicylate) of the adhesive composition of the present invention, and Figure 2 shows the transdermal absorption of the same active ingredient. Also Tosai Q-1'l! 5 ÷ standard procedural amendment (
Spontaneous) April 1982 138 1. Indication of the case 1988 Patent Application No. 56047 2. Name of the invention Patch composition 3. Relationship with the person making the amendment Applicant's address name (091) Kao Stocks Company 4, agent name (6870) Patent attorney Miko Ariga, -1
1 Address Same as above Koji Ryo. Name (7756) Patent Attorney Toshio Takano'::
l'i・1 Address Same as above 1--2J6
, Column 7 of "Detailed Description of the Invention" of the specification to be amended, contents of the amendment (1) In the specification, page 6, line 12, "dj-kanfurt" toraru is changed to "dl-kanfur, to". correct. (2) Same, page 7, line 3, "5-30%" is corrected to "5-50%."

Claims (1)

【特許請求の範囲】[Claims] 1、水溶性高分子物質1〜30重量%、有効成分以外の
油成分2〜20重量%、水分30重量%以上、油性ゲル
化剤1〜15%及び有効成分を含有することを特徴とす
る貼付剤組成物。
1. Contains 1 to 30% by weight of a water-soluble polymeric substance, 2 to 20% by weight of an oil component other than the active ingredient, 30% by weight or more of water, 1 to 15% of an oil-based gelling agent, and an active ingredient. Patch composition.
JP5604787A 1987-03-11 1987-03-11 Plaster composition Granted JPS63222113A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5604787A JPS63222113A (en) 1987-03-11 1987-03-11 Plaster composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5604787A JPS63222113A (en) 1987-03-11 1987-03-11 Plaster composition

Publications (2)

Publication Number Publication Date
JPS63222113A true JPS63222113A (en) 1988-09-16
JPH0567127B2 JPH0567127B2 (en) 1993-09-24

Family

ID=13016169

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5604787A Granted JPS63222113A (en) 1987-03-11 1987-03-11 Plaster composition

Country Status (1)

Country Link
JP (1) JPS63222113A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003131A1 (en) * 1994-07-22 1996-02-08 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneously absorbable preparation
JP2006206540A (en) * 2005-01-31 2006-08-10 Hisamitsu Pharmaceut Co Inc Sheet-like pack preparation and method for producing the same
WO2008016077A1 (en) * 2006-08-04 2008-02-07 Hisamitsu Pharmaceutical Co., Inc. Adhesive preparation
WO2020262057A1 (en) * 2019-06-24 2020-12-30 帝國製薬株式会社 Water-based adhesive patch

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54143517A (en) * 1978-04-28 1979-11-08 Hisamitsu Pharmaceut Co Inc Novel poultice and its preparation
JPS5742617A (en) * 1980-08-27 1982-03-10 Teikoku Seiyaku Kk Flexible cataplasma
JPS6067416A (en) * 1983-09-17 1985-04-17 デイナミ−ト・ノ−ベル・アクチエンゲゼルシヤフト Gel or gel-containing composition and manufacture

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54143517A (en) * 1978-04-28 1979-11-08 Hisamitsu Pharmaceut Co Inc Novel poultice and its preparation
JPS5742617A (en) * 1980-08-27 1982-03-10 Teikoku Seiyaku Kk Flexible cataplasma
JPS6067416A (en) * 1983-09-17 1985-04-17 デイナミ−ト・ノ−ベル・アクチエンゲゼルシヤフト Gel or gel-containing composition and manufacture

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003131A1 (en) * 1994-07-22 1996-02-08 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneously absorbable preparation
JP2006206540A (en) * 2005-01-31 2006-08-10 Hisamitsu Pharmaceut Co Inc Sheet-like pack preparation and method for producing the same
WO2008016077A1 (en) * 2006-08-04 2008-02-07 Hisamitsu Pharmaceutical Co., Inc. Adhesive preparation
US8455376B2 (en) 2006-08-04 2013-06-04 Hisamitsu Pharmaceutical Co., Inc. Adhesive preparation
JP5230423B2 (en) * 2006-08-04 2013-07-10 久光製薬株式会社 Patch
US8809615B2 (en) 2006-08-04 2014-08-19 Hisamitsu Pharmaceutical Co., Inc. Adhesive preparation
US9233184B2 (en) 2006-08-04 2016-01-12 Hisamitsu Pharmaceutical Co., Inc. Adhesive preparation
WO2020262057A1 (en) * 2019-06-24 2020-12-30 帝國製薬株式会社 Water-based adhesive patch
CN114007594A (en) * 2019-06-24 2022-02-01 帝国制药株式会社 Aqueous patch

Also Published As

Publication number Publication date
JPH0567127B2 (en) 1993-09-24

Similar Documents

Publication Publication Date Title
CA2000401C (en) Percutaneous pharmaceutical preparation
US6207184B1 (en) Hydrophilic adhesive masses
JPH03220120A (en) Acrylic gel material and acrylic gel preparation
CN108553452A (en) The adhesion preparation composition obtained by blending drug, organic solvent, lipophilicity matrix and powder
JPH0662401B2 (en) Ketoprofen-containing patch
JPS5936608A (en) Novel application drug
CA2041330C (en) Percutaneously absorbable eperisone or tolperisone preparation
JP3276188B2 (en) Patch and method for producing the same
JPS63222113A (en) Plaster composition
JP5175041B2 (en) Hydrophilic adhesive, hydrophilic external skin adhesive composition and hydrophilic patch using the same
JPS62148422A (en) Therapeutical system
AU2004298930B2 (en) Transdermal delivery system of hormones without penetration enhancers
JPH02115119A (en) Automatic adhesive apparatus for percutaneous administration of effective component
JPH10265371A (en) Transcutaneous absorption plaster
JPWO2012090322A1 (en) Patch
AU2018348802A1 (en) Transdermal therapeutic system for the transdermal administration of guanfacine comprising at least one additive
JP3193161B2 (en) Transdermal absorption preparation
JP3427445B2 (en) Cream
JPH10316560A (en) Plaster
JP3406188B2 (en) Patch
JPH03291218A (en) Plaster
JPH11199519A (en) Preparation for external use for skin
JP2017190309A (en) Rivastigmine percutaneously absorbable preparation
JPH04321623A (en) Plaster for dermal administration of estriol
JPH10316825A (en) Adhesive composition

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term